Not Signed In -
Ear, Nose, And Throat Conditions |
ENT |
Clinical Trial: Reproducibility of the aCGH System Using Whole Blood Samples
This study is not yet open for patient recruitment.
Verified by Abbott Molecular September 2005
|
Purpose
The objectives of this study are to validated the perfomance characveristics of the GeneTrait CGH Microarray System DX. Reproducibility among sites, lots, and operators will be evaluated.
| Condition |
|---|
| Multiple genetic conditions will be studied. |
MedlinePlus consumer health information
Study Type: Observational
Study Design: Cross-Sectional, Defined Population, Prospective Study
Official Title: Reproducibility of the GeneTrait™ CGH Microarray System DX Using Whole Blood Samples
Eligibility
Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- must be able to donate at least 10 mL of whole blood
- must be able to provide consent, or parental consent and patient assent (if applicable)
- must be currently followed as a patient of a genetic clinic or counselor at one of the recruting sites
- must have at least one chromosomal change that is detectable by the GeneTrait CGH Microarray System DX as determined by karyotype and/or FISH analysis (within any of the 73 critical regions)
Exclusion Criteria:
- unable to donate at least 10 mL of whole blood
- unable to provide consent, or parental consent and patient assent (if applicable)
- no currently followed as a patient of a genetic clinic or counselor at one of the recruting sites
- does have at least one chromosomal change that is detectable by the GeneTrait CGH Microarray System DX as determined by karyotype and/or FISH analysis (within any of the 73 critical regions)
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00214448
Lynda Hague 224-361-7101 lynda.hague@abbott.com
Andrew Hiar 224-361-7056 andrew.hiar@abbott.com
Andrew Hiar 224-361-7056 andrew.hiar@abbott.com
More Information
Study ID Numbers: 05-801
Last Updated: September 21, 2005
Record first received: September 20, 2005
ClinicalTrials.gov Identifier: NCT00214448
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-27
Last Updated: September 21, 2005
Record first received: September 20, 2005
ClinicalTrials.gov Identifier: NCT00214448
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-27
Resources
- A Guide for Parents - Questions and Answers: Fluid in the Middle Ear (Division of Bacterial & Mycotic Diseases, NCID, CDC, OPHS, HHS)
- Age Page: Hearing Loss (National Institute on Aging)
email this page
print this page
bookmark this page
feedback on this page
